Skip to main content

Advertisement

Log in

Loss-of-function of SHARPIN causes an osteopenic phenotype in mice

  • Original Article
  • Published:
Endocrine Aims and scope Submit manuscript

Abstract

SHARPIN is a novel protein thought to interact with SHANK family and is widely expressed in multiple tissues/cells, including osteoblasts and osteoclasts. Loss-of-function of Sharpin develops the chronic proliferative dermatitis mutation (CPDM) in mice as well as a severe inflammation in other organs. The actual function of SHARPIN is poorly understood. Our aim was to determine the functional roles of SHARPIN in bone metabolism by using CPDM mice. The skeletal phenotypes were determined by peripheral quantitative computed tomography, micro-computed tomography, and quantitative real-time RT-PCR, the cellular functions of osteoblasts and osteoclasts were investigated by ex vivo cell culture. Compared to wild-type controls, CPDM mice demonstrated significantly lower total and cortical bone mineral content and bone mineral density, trabecular and cortical bone volume, and trabecular number. The mRNA expression of Runx2, osterix, type I collagen, and osteocalcin was significantly lower in the bone from CPDM mice. Osteoclasts and osteoblasts from CPDM mice were functionally defective. Our result suggests that SHARPIN plays important regulating roles in bone metabolism. These functional roles may either come from systemic chronic inflammatory or directly signaling pathway within bone cells.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Y. Daigo, I. Takayama, S.M. Ward, K.M. Sanders, M.A. Fujino, Novel human and mouse genes encoding a shank-interacting protein and its upregulation in gastric fundus of W/WV mouse. J. Gastroenterol. Hepatol. 18, 712–718 (2003)

    Article  PubMed  CAS  Google Scholar 

  2. A. Marchler-Bauer, J.B. Anderson, M.K. Derbyshire, C. DeWeese-Scott, N.R. Gonzales, M. Gwadz, L. Hao, S. He, D.I. Hurwitz, J.D. Jackson, Z. Ke, D. Krylov, C.J. Lanczycki, C.A. Liebert, C. Liu, F. Lu, S. Lu, G.H. Marchler, M. Mullokandov, J.S. Song, N. Thanki, R.A. Yamashita, J.J. Yin, D. Zhang, S.H. Bryant, CDD: a conserved domain database for interactive domain family analysis. Nucleic Acids Res. 35, D237–D240 (2007)

    Article  PubMed  CAS  Google Scholar 

  3. S. Lim, C. Sala, J. Yoon, S. Park, S. Kuroda, M. Sheng, E. Kim, Sharpin, a novel postsynaptic density protein that directly interacts with the shank family of proteins. Mol. Cell Neurosci. 17, 385–397 (2001)

    Article  PubMed  CAS  Google Scholar 

  4. J. Jung, J.M. Kim, B. Park, Y. Cheon, B. Lee, S.H. Choo, S.S. Koh, S. Lee, Newly identified tumor-associated role of human Sharpin. Mol. Cell. Biochem. 340, 161–167 (2010)

    Article  PubMed  CAS  Google Scholar 

  5. R.E. Seymour, M.G. Hasham, G.A. Cox, L.D. Shultz, H. Hogenesch, D.C. Roopenian, J.P. Sundberg, Spontaneous mutations in the mouse Sharpin gene result in multiorgan inflammation, immune system dysregulation and dermatitis. Genes Immun. 8, 416–421 (2007)

    Article  PubMed  CAS  Google Scholar 

  6. H. HogenEsch, M.J. Gijbels, E. Offerman, J. van Hooft, D.W. van Bekkum, C. Zurcher, A spontaneous mutation characterized by chronic proliferative dermatitis in C57BL mice. Am. J. Pathol. 143, 972–982 (1993)

    PubMed  CAS  Google Scholar 

  7. H.I. Gallardo Torres, M.J. Gijbels, H. HegnEsch, G. Kraal, Chronic proliferative dermatitis in mice: neutrophil-endothelium interactions and the role of adhesion molecules. Pathobiology 63, 341–347 (1995)

    Article  PubMed  CAS  Google Scholar 

  8. M.J. Gijbels, H. HogenEsch, B. Blauw, P. Roholl, C. Zurcher, Ultrastructure of epidermis of mice with chronic proliferative dermatitis. Ultrastruct. Pathol. 19, 107–111 (1995)

    Article  PubMed  CAS  Google Scholar 

  9. M.J. Gijbels, C. Zurcher, G. Kraal, G.R. Elliott, H. HogenEsch, G. Schijff, H.F. Savelkoul, P.L. Bruijnzeel, Pathogenesis of skin lesions in mice with chronic proliferative dermatitis (cpdm/cpdm). Am. J. Pathol. 148, 941–950 (1996)

    PubMed  CAS  Google Scholar 

  10. H. HogenEsch, D. Boggess, J.P. Sundberg, Changes in keratin and filaggrin expression in the skin of CPDM mutant mice. Pathobiology 67, 45–50 (1999)

    Article  PubMed  CAS  Google Scholar 

  11. H. HogenEsch, S. Janke, D. Boggess, J.P. Sundberg, Absence of Peyer’s patches and abnormal lymphoid architecture in chronic proliferative dermatitis (cpdm/cpdm) mice. J. Immunol. 162, 3890–3896 (1999)

    PubMed  CAS  Google Scholar 

  12. R. Hardy, M.S. Cooper, Bone loss in inflammatory disorders. J. Endocrinol. 201, 309–320 (2009)

    Article  PubMed  CAS  Google Scholar 

  13. T.M. Schroeder, E.D. Jensen, J.J. Westendorf, Runx2: a master organizer of gene transcription in developing and maturing osteoblasts. Birth Defects Res. C Embryo Today 75, 213–225 (2005)

    Article  PubMed  CAS  Google Scholar 

  14. K. Nakashima, X. Zhou, G. Kunkel, Z. Zhang, J.M. Deng, R.R. Behringer, B. de Crombrugghe, The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell 108, 17–29 (2002)

    Article  PubMed  CAS  Google Scholar 

  15. C. Desbois, G. Karsenty, Osteocalcin cluster: implications for functional studies. J. Cell Biochem. 57, 379–383 (1995)

    Article  PubMed  CAS  Google Scholar 

  16. J. Lorenzo, M. Horowitz, Y. Choi, Osteoimmunology: interactions of the bone and immune system. Endocr. Rev. 29, 403–440 (2008)

    Article  PubMed  CAS  Google Scholar 

  17. L. Gilbert, X. He, P. Farmer, S. Boden, M. Kozlowski, J. Rubin, M.S. Nanes, Inhibition of osteoblast differentiation by tumor necrosis factor-alpha. Endocrinology 141, 3956–3964 (2000)

    Article  PubMed  CAS  Google Scholar 

  18. M.L. Renninger, R. Seymour, J.W. Lillard Jr., J.P. Sundberg, H. HogenEsch, Increased expression of chemokines in the skin of chronic proliferative dermatitis mutant mice. Exp. Dermatol. 14, 906–913 (2005)

    Article  PubMed  CAS  Google Scholar 

  19. I.M. Haeck, N.A. Hamdy, L. Timmer-de Mik, E.G. Lentjes, H.J. Verhaar, M.J. Knol, M.S. de Bruin-Weller, C.A. Bruijnzeel-Koomen, Low bone mineral density in adult patients with moderate to severe atopic dermatitis. Br. J. Dermatol. 161, 1248–1254 (2009)

    Article  PubMed  CAS  Google Scholar 

  20. A. Meixner, R. Zenz, H.B. Schonthaler, L. Kenner, H. Scheuch, J.M. Penninger, E.F. Wagner, Epidermal JunB represses G-CSF transcription and affects haematopoiesis and bone formation. Nat. Cell Biol. 10, 1003–1011 (2008)

    Article  PubMed  CAS  Google Scholar 

  21. J.E. Onyia, B. Miller, J. Hulman, J. Liang, R. Galvin, C. Frolik, S. Chandrasekhar, A.K. Harvey, J. Bidwell, J. Herring, J.M. Hock, Proliferating cells in the primary spongiosa express osteoblastic phenotype in vitro. Bone 20, 93–100 (1997)

    Article  PubMed  CAS  Google Scholar 

  22. K.J. Livak, T.D. Schmittgen, Analysis of relative gene expression data using real-time qPCR and the 2(-Delta Delta C(T)) method. Methods 25, 402–408 (2001)

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgment

This work was support by a grant to Dr. Xijie Yu from National Natural Science Foundation of China (No. 30872632).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Xijie Yu.

Additional information

Tian Xia and Yanhua Liang contribute equally to this work.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Xia, T., Liang, Y., Ma, J. et al. Loss-of-function of SHARPIN causes an osteopenic phenotype in mice. Endocr 39, 104–112 (2011). https://doi.org/10.1007/s12020-010-9418-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12020-010-9418-1

Keywords

Navigation